Related by context. All words. (Click for frequent words.) 72 diabetes mellitus DM 72 macroalbuminuria 71 T1DM 71 T2D 70 β blockers 70 atrophic gastritis 70 nonalcoholic steatohepatitis NASH 70 microalbuminuria 70 CC genotype 70 elevated triglyceride levels 70 PsA 70 ADPKD 70 hyperglycaemia 70 MetS 70 myeloproliferative diseases 69 paroxysmal AF 69 serum calcium levels 69 subclinical hypothyroidism 69 prostate cancer CaP 69 HeFH 69 PSADT 69 systolic hypertension 69 osteopenic 69 hepatocellular carcinomas 69 antiarrhythmic drug 68 INVEGA ® 68 systemic lupus erythematosus 68 virological response 68 HBeAg positive 68 diabetes mellitus 68 serum phosphate 68 heterozygotes 68 isolated systolic hypertension 68 platelet reactivity 68 colorectal adenoma 68 diabetes mellitus T2DM 68 intravesical therapy 68 primary aldosteronism 68 lipid abnormalities 68 antihypertensive therapy 68 proliferative diabetic retinopathy 68 leukemia AML 68 GH deficiency 68 atherogenic dyslipidemia 68 systemic lupus erythematosus SLE 68 NAFLD 68 HER2 overexpression 67 PCa 67 SHPT 67 anterior uveitis 67 dosage regimens 67 serum PTH 67 homozygotes 67 elevated LDL cholesterol 67 TNF antagonist 67 hypercalcemia 67 sulfasalazine 67 PAOD 67 glycated hemoglobin levels 67 HBeAg negative 67 hepatorenal syndrome 67 LV dysfunction 67 albumin excretion 67 serum urate levels 67 IPAH 67 hyperphenylalaninemia HPA due 67 TEAEs 67 euthymic patients 67 aminotransferases 67 dyslipidaemia 67 HIV HCV coinfected 67 carotid IMT 67 ABCB1 67 comorbid conditions 67 polyarticular 67 POAG 67 amnestic MCI 67 K ras mutations 67 lipid lowering agents 67 lymphocytosis 67 elevated ALT 67 postoperative AF 67 ALT elevations 67 interferon IFN 67 Relapsing Remitting Multiple Sclerosis 67 autonomic dysfunction 67 impaired glucose tolerance 67 hypertensives 66 intact parathyroid hormone 66 thyrotropin 66 elevated serum creatinine 66 NPH insulin 66 juvenile idiopathic arthritis 66 Severe Primary IGFD 66 extrapyramidal symptoms 66 alanine aminotransferase ALT 66 euthymic 66 euthyroid 66 liver histology 66 hematopoietic cancers 66 glomerular filtration 66 autoantibody levels 66 pentoxifylline 66 poor metabolizers 66 cytopenias 66 induce orthostatic hypotension 66 proteinuria 66 Hypotension 66 HbF 66 systolic dysfunction 66 secondary hyperparathyroidism 66 HbA1c levels 66 IFN beta 66 nondiabetic 66 abdominal adiposity 66 basal cell nevus syndrome 66 imatinib therapy 66 unfavorable cytogenetics 66 neovascular 66 thromboembolic complications 66 AAT deficiency 66 plasma pharmacokinetics 66 tocilizumab 66 serum cortisol 66 SCr 66 APTIVUS r 66 receptor tyrosine kinase inhibitor 66 HBeAg negative chronic hepatitis 66 selective modulator 66 isoenzyme 66 perioperative complications 66 nonvertebral fracture 66 irbesartan 66 BENICAR HCT 66 overt nephropathy 66 corticosteroid dose 66 colorectal liver metastases 66 hepatic fibrosis 66 Leydig cell 66 SSc 66 HbA 1c 66 nondepressed 66 Myelodysplastic Syndrome MDS 66 autoantibody positive 66 pheochromocytoma 66 epithelial tumors 66 Major Depressive Disorder 66 osteosarcomas 66 nephropathy 66 basal cell carcinoma BCC 66 aspartate aminotransferase AST 66 primary hypercholesterolemia 66 AST ALT 66 clomipramine 66 somatostatin analogs 65 subclinical atherosclerosis 65 improves glycemic 65 SGPT 65 depressive symptomatology 65 lupus nephritis 65 flutamide 65 ritonavir boosted 65 paclitaxel eluting stents 65 glycosylated hemoglobin HbA1c 65 serum testosterone 65 CrCl 65 psoriatic arthritis PsA 65 inotropic 65 pT3 65 Toxicities 65 antidiabetic drugs 65 aminotransferase levels 65 GSTP1 65 androgen deprivation 65 pancreatic adenocarcinoma 65 HGPIN 65 LV ejection fraction 65 hypercholesterolaemia 65 ovarian carcinoma 65 serum urate 65 gastric carcinoma 65 antiandrogens 65 Pioglitazone 65 hypercholesterolemia 65 onset diabetes mellitus 65 Non Alcoholic Steatohepatitis 65 rheumatoid factor 65 serum IGF 65 pyridostigmine 65 Nilotinib 65 cinacalcet 65 airway hyperresponsiveness 65 hyperalgesia 65 elevated LDH 65 intravitreal injections 65 elevated triglycerides 65 mycophenolate mofetil 65 nonvertebral fractures 65 glycemia 65 Asymptomatic 65 IDDM 65 CsA 65 bronchial hyperresponsiveness 65 overactive bladder symptoms 65 stage IIIB 65 demyelinating 65 leukocyte counts 65 choroidal neovascularization 65 superficial bladder cancer 65 HCV infected 65 CP CPPS 65 GISTs 65 acetabular dysplasia 65 2 diabetes T2D 65 fasting glucose levels 65 relapsed MM 65 thyroglobulin 65 albumin excretion rate 65 HOMA IR 65 elevated CRP 65 virological failure 65 Haptoglobin 65 GnRH agonists 65 HNSCC 65 neurological manifestations 65 MULTAQ 65 methotrexate therapy 65 transaminase levels 65 serum concentrations 65 Natalizumab 65 Retreatment 65 psychiatric comorbidity 65 EoE 65 decompensated heart failure 65 variceal bleeding 65 Chronic Heart Failure 65 hepatic cirrhosis 65 somatic symptoms 65 coadministration 65 juvenile idiopathic arthritis JIA 65 hypogonadotropic hypogonadism 65 hypovitaminosis D 65 recurrent VTE 65 IL 1ß 65 renal artery stenosis 65 Suicidal ideation 65 pancreatic insufficiency 65 alanine aminotransferase 65 tranylcypromine 65 liver metastasis 65 elevated creatinine 65 MADRS score 65 STRIDE PD 65 visilizumab 65 prostate cancer PCa 65 pharmacologic intervention 65 neuropsychiatric symptoms 65 histological subtype 65 stable angina 65 completely resected 65 adiponectin concentrations 65 triglyceride concentrations 65 CIMZIA ™ 65 paricalcitol 65 ACEIs 65 postoperative delirium 65 HoFH 65 pT2 65 Venous thromboembolism 65 QTc prolongation 65 Atypical antipsychotics 65 TT genotype 65 receptor blocker 65 receptor antagonists 65 apolipoproteins 65 diabetic gastroparesis 65 thromboembolic events 65 idiopathic myelofibrosis 65 insulin sensitizers 65 Clusterin 65 pDC 64 Neovascular AMD 64 metastatic malignant 64 hyperlipidaemia 64 diabetic nephropathy 64 metastatic renal cell carcinoma 64 Tasimelteon 64 reflux symptoms 64 carotid stenosis 64 penetrance 64 Thrombocytopenia 64 T#I [002] 64 colorectal carcinoma 64 serum creatinine levels 64 desvenlafaxine succinate 64 Rheumatoid Arthritis RA 64 adverse cytogenetics 64 grade cervical intraepithelial 64 VAPRISOL 64 CTEPH 64 NSTEMI 64 salmeterol HFA MDI 64 LUTS 64 blood phenylalanine Phe 64 thyrotropin levels 64 left ventricular dysfunction 64 serum folate concentrations 64 HER2 expression 64 Monotherapy 64 micafungin 64 DMARD 64 apolipoprotein B 64 NMIBC 64 haematologic 64 leukemia CLL 64 herpes zoster shingles 64 periprocedural 64 hematologic toxicity 64 missense mutation 64 levodopa therapy 64 microvascular complications 64 dopaminergic therapy 64 familial ALS 64 renal insufficiency 64 adrenalectomy 64 antiangiogenic therapy 64 subclinical hyperthyroidism 64 affective psychoses 64 familial hypercholesterolemia 64 hemoglobin A1c levels 64 Prehypertension 64 neoplasm 64 OSAHS 64 μmol L 64 DFMO 64 Enzastaurin 64 metformin sulfonylurea 64 neurocognitive impairment 64 rs# [001] 64 salmeterol fluticasone 64 renal tumors 64 pharmacokinetic interactions 64 haloperidol Haldol 64 elevated homocysteine 64 bezafibrate 64 pCR 64 intracranial hemorrhage ICH 64 CLA supplementation 64 Apolipoprotein B 64 CTAP# Capsules 64 APOE e4 64 Impaired Glucose Tolerance 64 LHRH agonists 64 plasma triglycerides 64 typical antipsychotics 64 chronic eosinophilic leukemia 64 HSCT 64 aripiprazole 64 cis retinoic acid 64 leukemia ALL 64 hyperinsulinemia 64 prednisone prednisolone 64 metastatic RCC 64 acarbose 64 TMC# r 64 AGILECT R 64 NATRECOR ® 64 rFVIIa 64 androgen deficiency 64 hyperoxaluria 64 normotensive 64 elevated IOP 64 Sjögren syndrome 64 diastolic hypertension 64 functional dyspepsia 64 comorbid anxiety 64 immunocompetent 64 oral antidiabetic medication 64 neovascular glaucoma 64 severe renal impairment 64 hypophosphatemia 64 heterozygous FH 64 troponin T 64 chronic HCV 64 prognostic variables 64 cirrhotic patients 64 EDSS scores 64 NNRTI resistance 64 posaconazole 64 myeloproliferative neoplasms 64 prostate carcinoma 64 COPAXONE R 64 bioavailable testosterone 64 gastric adenocarcinoma 64 relapsed ALL 64 immunomodulatory therapy 64 β2 64 lumbar spine BMD 64 HMGA1 64 canakinumab 64 rs# [004] 64 nondiabetic patients 64 hematological parameters 64 pulmonary hypertension PH 64 follicular lymphoma FL 64 LY# [003] 64 activating mutation 64 tumor histology 64 CVD mortality 64 mRNA expression 64 subclinical 64 Helicobacter pylori eradication 64 null mice 64 subependymal giant cell 64 Ischemic 64 neutrophil counts 64 coinfected patients 64 overt hypothyroidism 64 Ejection Fraction 64 antihypertensive drugs 64 JAK2 enzyme 64 baseline HbA1c 64 Decitabine 64 CYT# potent vascular disrupting 64 artery stenosis 64 Hashimoto thyroiditis 64 hypercalciuria 64 pulmonary exacerbations 64 PSA nadir 64 dopamine partial agonist 64 PEG IFN 64 patientswith 64 severe neutropenia 64 vWD 64 IGFBP 64 fulminant 64 proliferative retinopathy 64 LPS induced 64 glucose homeostasis 64 metaplasia 64 adalimumab 64 mixed hyperlipidemia 64 eosinophilia 64 radiotherapy RT 64 MGUS 64 NATRECOR R 64 amisulpride 64 steatohepatitis 64 acute GvHD 64 macrovascular disease 64 amnestic mild cognitive impairment 64 elevated fasting glucose 64 nonalcoholic steatohepatitis 64 chronicity 64 myeloproliferative disorders 64 decompensated cirrhosis 64 stratifying patients 64 metabolic parameters 64 Diabetes Mellitus 63 venlafaxine Effexor 63 TNFalpha 63 receptor antagonism 63 serum triglycerides 63 leiomyomas 63 gefitinib Iressa 63 parkinsonism 63 beta blocker therapy 63 Metastatic Prostate Cancer 63 NIDDM 63 tumor necrosis 63 antiplatelet medications 63 certolizumab 63 definite stent thrombosis 63 myelofibrosis polycythemia vera 63 glitazones 63 urothelial carcinoma 63 microscopic hematuria 63 Dasatinib 63 sustained virological response 63 renal cysts 63 myeloperoxidase 63 metabolic disturbances 63 plasma folate 63 histologically confirmed 63 genotypic resistance 63 idiopathic Parkinson disease 63 arterial calcification 63 hydroxyvitamin D levels 63 baseline LDH 63 Hydroxyurea 63 HbA 1c levels 63 Exacerbations 63 Diabetic nephropathy 63 1 diabetes T1D 63 biochemical relapse 63 vidofludimus 63 uric acid lowering 63 DAPT 63 riociguat 63 IV NSCLC 63 nitrotyrosine 63 thrombocytosis 63 urinary symptoms 63 nicardipine 63 seminomas 63 non metastatic osteosarcoma 63 serum HBV DNA 63 lowest tertile 63 inhibitor RG# 63 seropositivity 63 glatiramer acetate 63 idarubicin 63 morphometric vertebral fractures 63 bendamustine 63 leucopenia 63 mesalazine 63 de novo AML 63 CK MB 63 decitabine 63 vertebral fracture 63 TKI therapy 63 antiandrogen 63 antiretroviral naive 63 torsade de pointes 63 hypogonadal 63 glucocorticoid therapy 63 nephrotoxicity 63 anemia hemoglobin 63 pouchitis 63 prucalopride 63 Ranolazine 63 multivessel disease 63 vWF 63 ertapenem 63 sulphonylureas 63 VADT 63 BMPR2 63 comorbid depression 63 severe hypoglycemia 63 recurrent glioblastoma multiforme 63 teriflunomide 63 Pharmacokinetics PK 63 lowering blood glucose 63 Dapagliflozin 63 insulin detemir 63 renal impairment 63 ALT flares 63 polyp recurrence 63 serum lipid levels 63 variant allele 63 perfusion abnormalities 63 beta interferons 63 cranial irradiation 63 tumor xenograft models 63 pramlintide 63 metabolic abnormalities 63 CYP#C# [001] 63 perioperative morbidity 63 periprocedural MI 63 chloride secretion 63 AA Amyloidosis 63 teriparatide 63 glargine 63 NOMID 63 endotoxemia 63 Elitek 63 intermittent claudication 63 elevated uric acid 63 glulisine 63 interleukin IL -# 63 homozygous FH 63 microvascular disease 63 potassium sparing diuretics 63 posttransplant 63 dose dependently 63 umol L 63 Adenomas 63 tirofiban 63 Cardiotoxicity 63 weekly subcutaneous injections 63 advanced adenomas 63 sodium glucose cotransporter 63 serum calcium 63 geographic atrophy 63 idiopathic PAH 63 NSTE ACS 63 Adalimumab 63 atherothrombotic 63 Fas ligand 63 FDG uptake 63 autoimmune thyroid 63 neutropaenia 63 hydroxychloroquine 63 invasive aspergillosis 63 somatostatin analog 63 concomitant medications 63 myelodysplastic myeloproliferative diseases 63 serum LDL cholesterol 63 Zavesca ® 63 gene polymorphism 63 CORE OM 63 Gleevec resistant 63 fasting plasma 63 sJIA 63 Subgroup analyzes 63 Lp PLA 2 63 gastric cardia 63 lactic acidosis 63 chronic HBV infection 63 antithrombotic therapy 63 CagA 63 thrombocytopenic patients 63 VEGF inhibitors 63 glucose intolerant 63 Hypogonadism 63 ß blockers 63 hyperparathyroidism 63 caspofungin 63 atherothrombotic events 63 transgene expression 63 symptomatic VTE 63 genetic polymorphisms 63 xanthine oxidase inhibitor 63 somatoform disorders 63 DMARDs 63 carotid plaque 63 renal dysfunction 63 hypercholesterolemic patients 63 familial amyloidotic polyneuropathy FAP 63 ischemic cardiomyopathy 63 asymptomatic carotid stenosis 63 Fludarabine 63 thyrotoxicosis 63 B7 H3 63 diabetes dyslipidemia 63 metformin monotherapy 63 intima media thickness 63 acromegalic patients 63 castrate resistant prostate cancer 63 APTIVUS 63 biochemical recurrence 63 dapagliflozin plus 63 mTOR inhibitors 63 Critical Limb Ischemia CLI 63 myopathy rhabdomyolysis 63 Renal Cell Carcinoma RCC 63 Subgroup analysis 63 gallstone disease 63 hepatocellular carcinoma HCC 63 elevated troponin 63 chromosomal rearrangement 63 XIENCE V PROMUS Stent 63 antihypertensive medications 63 Hyperlipidemia 63 carcinoids 63 QD dosing 63 operable breast cancer 63 ziprasidone 63 serum ALT 63 PASI scores 63 Barrett esophagus BE 63 hyperprolactinemia 63 papillary renal cell carcinoma 63 serum potassium 63 serum albumin 63 Follicular Lymphoma 63 florbetaben 63 MMSE score 63 glycated hemoglobin 63 anticholinergic agents 63 aripiprazole Abilify 63 chronic HCV infection 63 peritumoral brain edema 63 neurocognitive deficits 63 sulphonylurea 63 VaD 63 PKC inhibitors 63 plasma kallikrein 63 antidiabetic 63 carotid plaques 63 BMI z 63 rs# [002] 63 hippocampal atrophy 63 benazepril 63 subscale scores 63 detemir 63 Primary IGFD 63 seropositive patients 63 left ventricular systolic 63 PDGFR 63 virologic response 63 microvascular dysfunction 63 proliferator activated receptor 63 heavily pretreated 63 hepatic steatosis 63 lispro 63 hypoperfusion 63 Multiple Myeloma MM 63 neutropenia dehydration dyspnea 63 Doxil ® 63 nonpsychotic 63 multivariate analyzes 63 BENICAR 63 lipid elevations 63 PEGylated interferon beta 1a 63 subtrochanteric 63 antidepressant efficacy 63 poststroke 63 preoperative PSA 63 ibandronate 63 serous ovarian cancer 63 MMSE scores 63 adjunctive ABILIFY 63 sporadic ALS 62 TYGACIL 62 abacavir Ziagen 62 confidence interval #.#-#.# 62 TMP SMX 62 BARACLUDE ® 62 refractory CLL 62 azacitidine 62 histologic subtype 62 essential thrombocythemia 62 CMV infection 62 ErbB2 positive 62 hamartomas 62 relapsed SCLC 62 cystatin C 62 Leukemias 62 5alpha reductase 62 mCRC patients 62 apo B 62 serum phosphate levels 62 abnormal lipid 62 Pemetrexed 62 SJIA 62 psychiatric morbidity 62 Hypercholesterolemia 62 bladder carcinoma 62 tHcy 62 fluvastatin 62 paroxysmal atrial fibrillation 62 lupus erythematosus 62 EXJADE 62 aminotransferase 62 Papillary 62 haematological toxicity 62 hyperammonemia 62 Enzyme Replacement Therapy 62 ejection fractions 62 radical prostatectomy RP 62 serum estradiol 62 hypoglycemic episodes 62 albuminuria 62 hypereosinophilic syndrome 62 chronic periodontitis 62 IPL# 62 FLT3 mutations 62 CANCIDAS 62 hemorrhagic complications 62 neoplasia 62 imatinib resistance 62 KRAS mutations occur 62 endometrial carcinoma 62 smoldering multiple myeloma 62 serum phosphorus 62 knee OA 62 transaminase elevations 62 lymphoproliferative disorders 62 coagulation abnormalities 62 systemic corticosteroid 62 metastatic neuroendocrine tumors 62 Juvenile Idiopathic Arthritis 62 renal cell carcinomas 62 serum PSA 62 mixed dyslipidemia 62 moderate renal impairment 62 cerebral vasospasm 62 chronic GVHD 62 invasive candidiasis 62 co morbidities 62 treat benign prostatic 62 glucocorticoid 62 tipranavir r 62 HCV genotype 62 hyperkalemia 62 GSTM1 62 histologically 62 vildagliptin 62 bone resorption 62 Endothelial dysfunction 62 Comorbidity 62 4mg/kg 62 elevated LDL 62 Generalized Anxiety Disorder 62 prolonged QT interval 62 epithelial ovarian cancer 62 adenomatous polyps 62 thromboembolic 62 chronic thromboembolic pulmonary 62 anticholinergics 62 μg liter 62 microglial activation 62 intravenous bisphosphonates 62 quetiapine Seroquel 62 INCB# [003] 62 cell lymphoma CTCL 62 Legg Calvé Perthes disease 62 systolic function 62 advanced adenoma 62 chlorambucil 62 ATACAND 62 bosentan 62 metabolic acidosis 62 anti leukemic 62 suicide attempters 62 Protelos 62 lactate dehydrogenase LDH 62 OAB symptoms 62 idraparinux 62 bleomycin 62 GnRH agonist 62 LRP5 62 alexithymia 62 chronic idiopathic thrombocytopenic purpura 62 Apidra ® 62 virologic failure 62 hypertriglyceridemia 62 IBS C 62 Castration Resistant Prostate Cancer 62 abacavir lamivudine 62 pg ml 62 relapsed AML 62 IGFBP 3 62 squamous cell carcinoma SCC 62 eplerenone 62 EGFR tyrosine kinase inhibitors 62 daunorubicin 62 Acute Coronary Syndromes ACS 62 Glucocorticoids 62 EBV infection 62 metabolic syndrome MetS 62 chronic hepatitis cirrhosis 62 pericardial effusion 62 adenoma recurrence 62 HES CEL 62 PSN# [002] 62 TIMP 1 62 hyperplastic 62 fasting insulin 62 gliclazide 62 LTBI 62 mg kg dose 62 affective psychosis 62 diastolic function 62 femoral neck fracture 62 JAK2 V#F 62 downregulation 62 cardiac troponin 62 adenocarcinomas 62 atherothrombosis 62 ARCOXIA 62 plasma uric acid 62 glomerular filtration rate 62 Thiazolidinediones 62 hypoglycemic events 62 hypomagnesemia 62 nodal metastasis 62 undergoing radical prostatectomy 62 triiodothyronine 62 neurocognitive function 62 nonischemic 62 breast carcinoma 62 biphasic insulin aspart 62 psychiatric comorbidities 62 carotid intima media 62 endothelial activation 62 C#Y 62 atypical neuroleptics 62 Chronic Hepatitis C 62 CD#b 62 nonobese 62 hemodialysis patients 62 mepolizumab 62 monoclonal anti 62 neurologic symptoms 62 impaired fasting glucose 62 basal bolus regimen 62 mineralocorticoid 62 hemoglobin A1c HbA1c 62 urate levels 62 IgA deficiency 62 serum triglyceride levels 62 oral antidiabetic drugs 62 Severe Sepsis 62 adrenal suppression 62 severe hypoglycaemia 62 hyper IgE syndrome 62 EBRT 62 angiotensin converting enzyme inhibitors 62 oxcarbazepine 62 hyperhomocysteinemia 62 airway hyper responsiveness 62 cTnI 62 dalteparin 62 PON1 62 airflow obstruction 62 parkinsonian symptoms 62 pulmonary metastases 62 antidiabetic medication 62 unstable angina pectoris 62 dysglycemia 62 postoperative morbidity 62 EDSS score 62 familial pancreatic cancer 62 VUR 62 Erythropoietic therapies may 62 polycythemia vera PV 62 neovascular AMD 62 bacterial prostatitis 62 lymphocyte counts 62 urinary N telopeptide 62 lipid parameters 62 parkinsonian 62 Safinamide 62 erythropoietic 62 tolvaptan 62 RISPERDAL ® 62 metastatic malignant melanoma 62 Lp PLA2 62 SGOT 62 liver transplant recipients 62 triacylglycerol concentrations 62 arthropathy 62 Heritability 62 DAS# scores 62 DAS# remission 62 proband 62 neurodevelopmental impairment 62 HMG CoA reductase inhibitors 62 PIGF 62 cardiac repolarization 62 left ventricular hypertrophy 62 subsyndromal 62 cerebral infarctions 62 evaluable subjects 62 EFFEXOR XR 62 HMG CoA reductase inhibitor 62 beta 1a 62 PlGF 62 EGFR mutations 62 lupus anticoagulant 62 methimazole 62 hepatic metastases 62 Kinoid 62 colorectal cancer CRC 62 MTHFR 62 atherosclerotic disease 62 prostanoid 62 preserved ejection fraction 62 antibody titer 62 patients undergoing CABG 62 epoetin beta 62 Nucleoside 62 plasma lipid 62 reduce serum phosphate 62 hip BMD 62 CIN3 62 schizophrenia CIAS 62 antithrombotics 62 shorter telomere length 62 peginterferon alfa 2a 62 cardiac dysfunction 62 cervical lymph nodes 62 plasma renin activity 62 Glimepiride 62 multicentric 62 % Confidence Interval 62 IOP lowering 62 Testosterone deficiency 62 thiazide diuretic 62 Aortic stenosis 62 ZOLINZA 62 AGILECT ® 62 Bronchiectasis 62 Microalbuminuria 62 somatostatin analogue 62 steroid dexamethasone 62 endometrial hyperplasia 62 myelodysplastic syndrome MDS 62 macrovascular complications 62 primary hyperparathyroidism 62 Gorlin syndrome 62 nonfasting triglyceride levels 62 prognostic biomarker 62 cardioembolic stroke 62 multivariate Cox 62 multivariable analysis 62 H. pylori eradication